Piper Sandler Maintains Overweight on CVS Health, Lowers Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jessica Tassan has maintained an Overweight rating on CVS Health (NYSE:CVS), but lowered the price target from $85 to $82.
September 01, 2023 | 4:54 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Piper Sandler has maintained an Overweight rating on CVS Health, but lowered the price target from $85 to $82.
The news is directly related to CVS Health. While the Overweight rating suggests that Piper Sandler expects the stock to outperform the market, the lowering of the price target may create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100